NasdaqGS:AMGNBiotechs
Is It Time To Reassess Amgen (AMGN) After Its Strong Multi Year Share Price Run
If you are wondering whether Amgen at around US$324.39 is still offering value after a solid run, this article walks through what the current price really implies.
The stock is down 1.6% over the past week and 8.7% over the past month, yet it is still up 1.0% year to date and 21.1% over the past year, with 3 year and 5 year returns of 58.8% and 53.3% respectively. This naturally raises questions about how much of its potential is already in the price.
Recent headlines around Amgen have...